Vitalhub Corp.

TSX:VHI.TO

Medical - Healthcare Information Services

Healthcare
$6.66 +0.56%

+$0.04 today

Market cap
$421.84M
Beta
0.77
P/E (TTM)
62.1
EPS (TTM)
$0.12
52W Low $6.67High $14.64

Volume 0.23M

Average 0.41M

VHI.TO Operating Cash Flow

Cash generated by the company's core business operations during the period.

Vitalhub Corp.TSX: VHI.TO

Operating Cash Flow · Q1 FY2026 · quarter ended Mar 2026

Operating cash flow declines year over year

Q1 FY2026 operating cash flow of CA$2.32M fell 12.8% year over year, ahead of the -49.3% change in trailing-twelve-month operating cash flow. Over 3 fiscal years it compounded at +10.8% a year.

Context

  • Operating cash flow amounted to 7.6% of revenue in FY2025, down 14.4 pp from a year earlier.
  • Operating cash flow increased in 1 of the last 3 fiscal years.

What to watch

Whether quarterly growth of -12.8% holds above the trailing-twelve-month pace of -49.3%.

Sources:Cash FlowText generated from reported figures; not investment advice.

Latest quarterMar 2026
CA$2.32M+136.3% QoQ
Last fiscal yearDec 2025
CA$8.32M-45.0% YoY
LTMMar 2026
CA$7.98M-49.3% YoY
Operating Cash Flow past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-12.8%——
1 year-45.0%——
3-year CAGR+10.8%——
5-year CAGR——
10-year CAGR——

Operating Cash Flow history

CAD · from the cash flow

Latest · FY2025
8.32M CAD
Year-over-year change
-45.0%

Operating Cash Flow vs competitors

How VHI.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so operating cash flow is compared through growth and share of revenue rather than absolute size.
  • Its year-over-year change of -49.3% is the 5th highest of 7, against a peer median of -5.0%.
  • Operating cash flow amounts to 6.7% of revenue for VHI.TO, versus a peer median of 14.6%.
VHI.TO Competitors
Operating Cash Flow for VHI.TO and competitors
Company Period LTM YoY 3-year CAGR% of revenue
GUD.TOKnight Therapeutics Inc.LTM Mar 2026CA$105.56M CAD+1224.5%+20.2%20.7%
CPH.TOCipher Pharmaceuticals Inc.LTM Mar 2026$30.09M USD+41.1%+41.9%59.1%
TSND.TOTerrAscend Corp.LTM Mar 2026$22.04M USD-33.2%—8.4%
ACB.TOAurora Cannabis Inc.LTM Mar 2026CA$13.51M CAD-184.4%-51.1%4.2%
EDT.TOSpectral Medical Inc.LTM Mar 2026CA$11.11M CAD+23.1%-1.3%402.5%
VHI.TOVitalhub Corp.LTM Mar 2026CA$7.98M CAD-49.3%+10.8%6.7%
KSI.TOKneat.com, Inc.LTM Mar 2026CA$2.29M CAD-87.9%+60.0%3.4%
Peer median (excluding VHI.TO) —-5.0%+20.2%14.6%

Competitors are the stored peer set for VHI.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Cash Flow Statement

CAD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Net Income(1.95M)1.21M4.55M3M6.11M
Depreciation & Amortization2.68M3.87M4.98M5.96M11.08M
Deferred Income Tax(439.35K)151.46K00(3.12M)
Stock-Based Compensation1.72M1.14M1.16M2.34M2.65M
Change in Working Capital(2.14M)(997.91K)9.29M3.57M(8.27M)
Accounts Receivables(1.89M)(2.04M)2.4M(3.99M)10.14M
Inventory245.69K(504.68K)534.79K(69.97K)176.51K
Accounts Payables(662.47K)(945.73K)957.25K2.7M(9.91M)
Other Working Capital169.6K2.49M5.4M4.93M(8.68M)
Other Non-Cash Items82.43K740.39K497.09K254.53K(125.74K)
Operating Cash Flow(49.97K)6.12M20.47M15.13M8.32M
Capital Expenditures(259.61K)(295.05K)(290.11K)(883.72K)(423.15K)
Acquisitions (Net)(9.8M)(21.55M)(1.84M)(28.42M)(50.36M)
Purchases of Investments0000(160.32M)
Sales of Investments000098.77M
Other Investing Activities(457.86K)(1.54M)(2.02M)(2.09M)1.23M
Investing Cash Flow(10.06M)(21.84M)(4.15M)(31.39M)(111.11M)
Debt Repayment(372.24K)(516.17K)(399.55K)(366.37K)(595.98K)
Common Stock Issued3.54M16.3M150.73K37.51M105.18M
Common Stock Repurchased0(215.42K)(39.07K)00
Dividends Paid00000
Other Financing Activities3.54M836.22K150.73K1.94M0
Financing Cash Flow3.17M16.4M(287.89K)39.09M104.59M
Effect of Forex Changes(62.88K)381.66K(11.18K)268.5K(744.45K)
Net Change in Cash(7M)1.06M16.03M23.09M1.05M
Free Cash Flow(309.58K)5.83M20.18M14.24M7.9M

Vitalhub Corp.

TSX:VHI.TO

Intrinsic Alpha fair value

Locked

Current Price

$6.66

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.